TRV GP IV, LLC
TRV GP IV, LLC is a U.S.-based investment firm headquartered in Boston, Massachusetts. The firm primarily manages hedge fund portfolios and is known for managing concentrated positions in biotechnology and therapeutics companies. Founded in 2016, TRV GP IV, LLC operates with a lean team structure, as is common in specialized hedge funds, though the precise employee count is not publicly disclosed. It serves institutional investors and other qualified clients, pursuing investment opportunities largely in the healthcare and biotechnology sectors.
Investment Strategy
TRV GP IV, LLC focuses its investment strategy primarily on equity investments in innovative healthcare and biotechnology companies. The fund takes highly concentrated positions, as evidenced by its small number of significant holdings such as Tango Therapeutics, Pliant Therapeutics, and Fulcrum Therapeutics. This approach seeks to generate outsized returns by backing companies with high growth potential and industry-disrupting advances, often holding these positions over extended periods. TRV GP IV leverages deep sector expertise to identify and support companies at the forefront of therapeutic innovation, with a strong emphasis on long-term value creation.
Top Holdings
Equity Positions (3)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
T TNGX | TANGO THERAPEUTICS, INC. | 52.85% | $86.3M | 16,859,075 | $12.93 | $5.12 | +$63.2M |
M MAZE | MAZE THERAPEUTICS, INC. | 45.63% | $74.5M | 6,073,958 | $11.01 | $12.27 | +$7.7M |
P PLRX | PLIANT THERAPEUTICS, INC. | 1.51% | $2.5M | 2,132,867 | $32.46 | $1.16 | -$405.2K |